Target Price | $21.33 |
Price | $11.45 |
Potential |
86.32%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target Anika Therapeutics, Inc. 2026 .
The average Anika Therapeutics, Inc. target price is $21.33.
This is
86.32%
register free of charge
$24.00
109.61%
register free of charge
$19.00
65.94%
register free of charge
|
|
A rating was issued by 3 analysts: 3 Analysts recommend Anika Therapeutics, Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Anika Therapeutics, Inc. stock has an average upside potential 2026 of
86.32%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 119.91 | 109.95 |
0.73% | 8.31% | |
EBITDA Margin | 4.85% | 0.01% |
67.65% | 99.79% | |
Net Margin | -47.03% | -13.65% |
31.29% | 70.97% |
3 Analysts have issued a sales forecast Anika Therapeutics, Inc. 2025 . The average Anika Therapeutics, Inc. sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an Anika Therapeutics, Inc. EBITDA forecast 2025. The average Anika Therapeutics, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 Anika Therapeutics, Inc. Analysts have issued a net profit forecast 2025. The average Anika Therapeutics, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -3.83 | -1.05 |
32.09% | 72.58% | |
P/E | negative | |
EV/Sales | 1.01 |
3 Analysts have issued a Anika Therapeutics, Inc. forecast for earnings per share. The average Anika Therapeutics, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Anika Therapeutics, Inc....
Analyst | Rating | Action | Date |
---|---|---|---|
Barrington Research |
Locked
➜
Locked
|
Locked | May 12 2025 |
Barrington Research |
Locked
➜
Locked
|
Locked | Mar 13 2025 |
Barrington Research |
Locked
➜
Locked
|
Locked | Nov 01 2024 |
Barrington Research |
Locked
➜
Locked
|
Locked | Oct 22 2024 |
Analyst Rating | Date |
---|---|
Locked
Barrington Research:
Locked
➜
Locked
|
May 12 2025 |
Locked
Barrington Research:
Locked
➜
Locked
|
Mar 13 2025 |
Locked
Barrington Research:
Locked
➜
Locked
|
Nov 01 2024 |
Locked
Barrington Research:
Locked
➜
Locked
|
Oct 22 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.